Litigation

Recent Posts

Negligent Design Claim Reinstated on Appeal In Diet Drug Death Case
Posted on 3 Aug 2010 by Michael Lefkowitz

PHILADELPHIA - (Mealey's) A claim for negligent design is not subsumed in Pennsylvania's prohibition on strict liability claims against pharmaceutical manufacturers, the state Superior Court ruled Aug. 2 in a case asserting that Wyeth's diet... Read More

Tags: negligent design , Wyeth , PPH , dexfenfluramine , tort , personal injury , Patsy Lance , diet drugs , Patsy Lance v. Wyeth , Redux , Litigation , lawsuit , Catherine Ruth Lance , primary pulmonary hypertension

Pa. Supreme Court Says Drug Companies Can Be Sued For Marketing Dangerous Drugs
Posted on 23 Jan 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) Pennsylvania law allows drug companies to be sued if they fail to stop marketing drugs known to be unreasonably harmful, and the manufacturers are not immune from being sued for damages for lack of due care, the Pennsylvania... Read More

Tags: et al. v. Wyeth , drugs , Pondimin , Wyeth , phentermine , PPH , diet drug , American Home Products Corp. , dexfenfluramine , Food and Drug Administration , Catherine Lance , marketing drugs , Pfizer , Pennsylvania Supreme Court , Patsy Lance , Pennsylvania , FDA , fen-phen , fenfluramine , National Childhood Vaccine Injury Act , Redux , Litigation , valvular heart disease , primary pulmonary hypertension